NCT00002214View on ClinicalTrials.gov

Phase I Trial of S-1153 in Patients With HIV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Capravirine

Trial Locations (1)

02215

Beth Israel Deaconess Med Ctr, Boston

Sponsors
All Listed Sponsors
lead

Lexigen Pharmaceuticals

INDUSTRY